Alere

Sensitivity problems with rapid antigen tests are also helping the more accurate rapid molecular tests gain wider acceptance, manufacturers said.

The portable device runs an isothermal amplification assay to detect genetic material from strains of tuberculosis in resource limited areas.  

The company immediately borrowed $255 million to pay part of the $680 million price tag for Alere's MeterPro cardiovascular and toxicology business and its BNP assay business.

The offer of $402 per share was made in connection with Abbott's acquisition of Alere, which was completed on Tuesday.

Abbott said in an SEC filing today that the "aggregate consideration" paid regarding the merger was about $4.6 billion and that Alere is now an Abbott subsidiary.

Abbott's tender offer to purchase all outstanding shares of Alere's Series B convertible perpetual preferred stock at $402 per share is now scheduled to expire on Oct. 3. 

The firm said that it will soon apply for a CLIA waiver of the second-generation test,which can report positive results in as little as five minutes

The firm said today that it has received all regulatory clearances to close the deal that it first proposed in February 2016.

The deal ends an investigation by the SEC into certain accounting practices by Alere's foreign subsidiaries. The company also consented to a cease-and-desist order. 

Investment banks Canaccord Genuity and Raymond James also raised their price targets on the company.

Pages

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.